These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Optical Coherence Tomography of Retinal Artery Occlusion Associated With Mucormycosis and COVID-19. Kaur R; Khan B; Sharma A JAMA Ophthalmol; 2021 Nov; 139(11):e214064. PubMed ID: 34787678 [No Abstract] [Full Text] [Related]
45. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review. Afzal S; Nasir M J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702 [TBL] [Abstract][Full Text] [Related]
46. COVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases. Arjun R; Felix V; Niyas VKM; Kumar MAS; Krishnan RB; Mohan V; Ansar A; Gautaam S; Lalitha S QJM; 2022 Jan; 114(11):831-834. PubMed ID: 34181023 [No Abstract] [Full Text] [Related]
47. COVID-19-associated mucormycosis-elucidating the etiology of this emerging entity. Sakthivel P; Ish P QJM; 2022 Jun; 115(6):421. PubMed ID: 34264350 [No Abstract] [Full Text] [Related]
48. Mucormycosis: time to address this deadly fungal infection. Stone N; Gupta N; Schwartz I Lancet Microbe; 2021 Aug; 2(8):e343-e344. PubMed ID: 35544192 [No Abstract] [Full Text] [Related]
49. Role of medial orbital wall decompression in COVID-19-associated rhino-orbital mucormycosis management. Murthy R; Bagchi A; Gote YS Indian J Ophthalmol; 2021 Dec; 69(12):3795-3796. PubMed ID: 34827060 [No Abstract] [Full Text] [Related]
53. [Pediatric rhino-orbital mucormycosis. First peruvian case in times of the COVID-19 pandemic]. Meregildo-Rodriguez ED; Espino-Saavedra WG Rev Peru Med Exp Salud Publica; 2021; 38(3):472-473. PubMed ID: 34932752 [No Abstract] [Full Text] [Related]
54. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply. Date PS; Choksi T; Ingole AB JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457 [No Abstract] [Full Text] [Related]
55. Mucormycosis-Related Vision Loss in COVID-19. Dhoot SK Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):173-174. PubMed ID: 35272556 [No Abstract] [Full Text] [Related]
56. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Raut A; Huy NT Lancet Respir Med; 2021 Aug; 9(8):e77. PubMed ID: 34090607 [No Abstract] [Full Text] [Related]
57. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19. Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738 [TBL] [Abstract][Full Text] [Related]
58. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Rudrabhatla PK; Reghukumar A; Thomas SV Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787 [TBL] [Abstract][Full Text] [Related]
59. Intestinal mucormycosis in a patient with COVID-19: A case report. Paliwal P; Rahar S; Sharma A; Gupta D; Ahuja A; Chauhan DS Indian J Pathol Microbiol; 2022; 65(2):475-477. PubMed ID: 35435400 [TBL] [Abstract][Full Text] [Related]
60. Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature. Ramphul K; Verma R; Kumar N; Ramphul Y; Mejias S; Lohana P Acta Biomed; 2021 Sep; 92(4):e2021271. PubMed ID: 34487063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]